THE FRONT PAGE
EDITOR'S NOTE: A busy day in the latent space. #Judgment and craft
BREAKING VECTORS
Tokyo researchers identify molecular pathway linking neurodegenerative therapies
By targeting common cellular mechanisms in both Alzheimer's and Parkinson's, the clinical trial yields a rare cross-disease therapeutic candidate. The trade-off remains the immense difficulty of crossing the blood-brain barrier consistently without triggering localized immune rejection.
MODEL ARCHITECTURES
LAB OUTPUTS
INFERENCE CORNER
